Seventy-two percent of CIOs in the survey thought the delay was positive. Twenty-eight percent thought the delay was a step in the wrong direction or thought it was a null event. Other findings from the survey include:
• Roughly 68 percent of CIO respondents said the postponement of ICD-10 was a good thing for the healthcare industry in general.
• Although most hospital CIOs believe the ICD-10 delay was a good thing, 84 percent will still push their ICD-10 projects forward as if the original Oct. 1, 2013, deadline were still in effect.
• When a new deadline is proposed, 76 percent believe it will not be more difficult to get organizational support.
• Eighty percent of hospital CIO respondents said they do not see a positive cost-benefit ratio in the ICD-10 conversion.
More Articles on ICD-10:
Health Affairs: ICD-10 Delay Should Be Used to Prepare for ICD-11, SNOMED
National Library of Medicine Releases SNOMED to ICD-10-CM Map
In the Fog of Delay: What’s Next for ICD-10?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
